Skip to main content
. 2016 Nov 24;2016(11):CD004028. doi: 10.1002/14651858.CD004028.pub4

Jia 2007.

Methods Allocation: randomised
Blinding: open label
Duration: 4 weeks
Design: parallel
Country: China
Participants Diagnosis: ICD‐10 schizophrenia
n = 80
Sex: male only
Age: 18‐50 years, mean 38.9 ± 11.0 years
History: duration of illness total, range 10‐25 years, mean 15.3 ± 9.1 years
Setting: inpatient.
Interventions 1. Sodium valproate + clozapine: valproate 400‐800 mg/d, clozapine dosage unclear; n = 40
2. Clozapine alone: dosage not reported; n = 40
Outcomes Clinical response: mental state (PANSS total)
 Adverse events: various events
Unable to use:
 Clinical response: positive symptoms, negative symptoms ‐ PANSS subscales (skewed data)
 Leaving the study early (no information provided)
Adverse events: TESS scores (no means and SDs reported)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomly assigned", p 3 "Pairs of participants with no significant differences in age, BMI, duration of illness, smoking, Clozapine dosage taken, co‐medication and PANSS score", were randomly divided into two equal groups"
Allocation concealment (selection bias) Unclear risk Not stated
Blinding of participants and personnel (performance bias) 
 Objective outcomes Low risk Not stated. No information about blinding provided, therefore assuming open‐label
Blinding of participants and personnel (performance bias) 
 Subjective outcomes High risk Not stated. No information about blinding provided, therefore assuming open‐label
Blinding of outcome assessment (detection bias) 
 Objective outcomes Low risk Not stated
Blinding of outcome assessment (detection bias) 
 Subjective outcomes High risk Not stated
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Not stated
Selective reporting (reporting bias) High risk TESS scores measured but no means and SDs reported; study authors only stated that no significant difference in TESS score between groups (P > 0.05). Study authors also selectively reported binary outcomes of a few adverse events, but didn't provide numbers for all adverse events
Other bias Unclear risk None obvious